文献速递临床试验与 GCP流行病学与生物统计

危重症患者肺炎的管理

Management of pneumonia in critically ill patients.
PubMed 文献 · BMJ · 2021-12-06

重症肺炎与高死亡率(短期和长期)及肺部和肺外并发症相关。危重症患者中,及时诊断和早期启动充分的抗菌治疗对改善生存至关重要,明确致病病原体对抗菌药物管理也很关键。然而,在多数患者中建立病原学诊断具有挑战性,尤其是有慢性基础疾病、既往接受过抗生素治疗以及接受机械通气的患者。此外,由于抗菌治疗必须为经验性,国家和国际指南推荐根据当地流行病学情况初始选择抗菌治疗;对于收入重症监护病房的患者,有特定的疾病管理建议。遵循肺炎指南与重症肺炎更好的结局相关。然而,关于重症肺炎持续且必要的研究领域广泛,涉及宿主免疫反应、病情严重程度评估、微生物病因、多重耐药病原体危险因素、诊断检测和治疗选择等不同视角。

要点

  • 重症肺炎与短期和长期高死亡率及肺部和肺外并发症相关。
  • 危重症患者早期启动充分抗菌治疗对改善生存至关重要。
  • 遵循肺炎指南与重症肺炎更好的结局相关。

核心结论

  • 重症肺炎与高死亡率(短期和长期)及肺部和肺外并发症相关;及时诊断和早期启动充分抗菌治疗对改善危重症患者生存至关重要。

主要发现

  • 在多数患者中建立病原学诊断具有挑战性,尤其是有慢性基础疾病、既往接受过抗生素治疗和接受机械通气的患者。
  • 由于抗菌治疗必须为经验性,国家和国际指南推荐根据当地流行病学情况初始选择抗菌治疗;对收入重症监护病房的患者有特定的疾病管理建议。
  • 遵循肺炎指南与重症肺炎更好的结局相关。

临床怎么用

  • 国家和国际指南推荐根据当地流行病学情况初始选择经验性抗菌治疗;对收入重症监护病房的患者有特定的疾病管理建议。
  • 遵循肺炎指南与重症肺炎更好的结局相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe pneumonia is associated with high mortality (short and long term), as well as pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of adequate antimicrobial treatment for severe pneumonia are crucial in improving survival among critically ill patients. Identifying the underlying causative pathogen is also critical for antimicrobial stewardship. However, establishing an etiological diagnosis is challenging in most patients, especially in those with chronic underlying disease; those who received previous antibiotic treatment; and those treated with mechanical ventilation. Furthermore, as antimicrobial therapy must be empiric, national and international guidelines recommend initial antimicrobial treatment according to the location's epidemiology; for patients admitted to the intensive care unit, specific recommendations on disease management are available. Adherence to pneumonia guidelines is associated with better outcomes in severe pneumonia. Yet, the continuing and necessary research on severe pneumonia is expansive, inviting different perspectives on host immunological responses, assessment of illness severity, microbial causes, risk factors for multidrug resistant pathogens, diagnostic tests, and therapeutic options.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Cillóniz C, Torres A, Niederman MS, et al. Management of pneumonia in critically ill patients. BMJ. 2021. PMID: 34872910. doi:10.1136/bmj-2021-065871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。